Search Results

Your search for Michael T. Schweizer, MD, and Daniel W. Lin, MD,Michael T. Schweizer, MD, and Daniel W. Lin, MD matches 2 pages

Showing 1 - 2

By Michael T. Schweizer, MD, and Daniel W. Lin, MD / August 25, 2020 - Supplement: Genitourinary Cancers Almanac

Nonmetastatic Castration-Resistant Prostate Cancer

Nonmetastatic castration-resistant prostate cancer arises in the subset of men with biochemically recurrent disease (ie, rising prostate-specific antigen [PSA] level after definitive therapy in the absence of metastases) who develop PSA progression after chronic exposure to androgen-deprivation...

prostate cancer

By Michael T. Schweizer, MD, and Daniel W. Lin, MD / June 25, 2019

Darolutamide in Nonmetastatic Castration-Resistant Prostate Cancer: Delaying Overt Metastatic Disease Is a Major Advance

Nonmetastatic (M0) castration-resistant prostate cancer arises in the subset of men with biochemically recurrent disease (ie, rising prostate-specific antigen [PSA] level after definitive therapy in the absence of metastases) who develop PSA progression after chronic exposure to...

Nov

Today In Oncology

Search Results

Your search for Michael T. Schweizer, MD, and Daniel W. Lin, MD,Michael T. Schweizer, MD, and Daniel W. Lin, MD matches 2 pages

Nonmetastatic Castration-Resistant Prostate Cancer

Darolutamide in Nonmetastatic Castration-Resistant Prostate Cancer: Delaying Overt Metastatic Disease Is a Major Advance

What Is the Impact of a Colon or Colorectal Cancer Diagnosis on Younger Adults?

International Cancer Organizations Present Collaborative Work During Oncology Event in China

Is There a Role for Neoadjuvant Chemotherapy in HR-Positive, HER2-Negative Early Breast Cancer?

Suicide-Related Mortality in Male AYA Cancer Survivors

Four-Year Asian Subpopulation Data From the CheckMate 816 Trial of Neoadjuvant Nivolumab Plus Chemotherapy in Resectable NSCLC